 |
市场调查报告书
商品编码
2008011
成人疫苗市场：依疫苗类型、技术、应用、分销管道和地区划分。Adult Vaccines Market, By Vaccine Type, By Technology, By Application, By Distribution Channel, By Geography |
||||||
2026年成人疫苗市场规模估计为328亿美元，预计2033年将达到516亿美元。预计2026年至2033年，该市场将以6.69%的复合年增长率成长。
| 报告范围 | 报告详情 | ||
|---|---|---|---|
| 基准年： | 2025 | 2026年市场规模： | 328亿美元 |
| 历史数据时期： | 2020年至2024年 | 预测期： | 2026年至2033年 |
| 2026年至2033年预测期间的复合年增长率： | 6.69% | 2033年市场规模预测： | 516亿美元 |
全球成人疫苗市场是预防性医疗保健市场的重要组成部分，旨在为18岁及以上提供免疫接种解决方案和服务。该市场对于预防疫苗可预防疾病和降低医疗保健成本至关重要。
成人疫苗与其他疫苗的不同之处在于，它们根据成人的疾病风险和免疫水平提供相应的免疫接种方案。此细分市场提供多种免疫接种方案，包括流感疫苗、肺炎链球菌疫苗、肝炎疫苗、人类乳突病毒（HPV）疫苗、脑膜炎双球菌疫苗和旅游疫苗，以及带状疱疹疫苗和呼吸道合胞病毒（RSV）疫苗等新型疫苗。
市场成长的驱动因素包括：人们对健康保健意识的提高、慢性疾病发生率上升导致免疫力减弱，以及卫生部门扩大疫苗接种建议的范围。新冠疫情也提高了人们对成人疫苗接种的认知度和接受度，进一步推动了市场成长。此外，包括mRNA在内的新型疫苗技术的研发有望提高疫苗效力，这将进一步刺激市场成长。
市场动态
全球成人疫苗市场受多种因素影响，这些因素共同创造了有利的成长环境。例如，人口老化使得成年人更容易感染疾病、肺炎链球菌感染和带状疱疹等疾病。此外，糖尿病和心臟病的发生率上升也使成年人更容易受到感染疾病。政府旨在降低医疗成本和推广预防医学的措施也产生了显着影响。国际旅行的增加和职场健康计划的实施也推动了疫苗需求的成长。此外，疫苗技术的进步提高了疫苗的有效性，并使其更容易被成年人获得。
然而，阻碍该市场成长的因素包括对疫苗的犹豫、高昂的研发成本以及监管障碍。此外，世界部分地区医疗基础设施落后也是限制市场成长的主要障碍。
儘管面临这些挑战，但新兴市场也蕴藏着许多机会，例如医疗基础设施的改善、可支配收入的增加以及预防医学的普及。例如，联合疫苗和数位技术的进步正在提高疫苗的可及性和有效性。
本次调查的主要特点。
- 本报告对全球成人疫苗市场进行了详细分析，给出了预测期（2026-2033 年）的市场规模（以十亿美元计）和复合年增长率（CAGR%），其中 2025 年为基准年。
- 本报告指出了各个细分市场的潜在商机，并说明了该市场中一系列有吸引力的投资提案。
- 此外，本研究还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域展望以及主要企业采取的竞争策略的关键见解。
- 本报告根据以下参数对全球成人疫苗市场的主要企业进行了分析：公司概况、产品系列、主要亮点、财务表现和策略。
- 透过利用本报告中提出的见解，企业行销负责人和经营团队可以就未来的产品发布、产品升级、市场扩张和行销策略做出明智的决策。
- 本报告面向该产业的各类相关人员，包括投资者、供应商、产品製造商、经销商、新参与企业和金融分析师。
- 相关人员可以透过分析全球成人疫苗市场中使用的各种策略矩阵轻鬆做出决策。
目录
第一章：研究目标与前提条件
- 研究目标
- 前提
- 简称
第二章 市场范围
- 报告摘要
- 市场定义和范围
- 执行摘要
第三章：市场动态、监管与趋势分析
- 市场动态
- 影响分析
- 主要亮点
- 法规环境
- 产品上市及核准
- PEST分析
- 波特的分析
- 市场机会
- 法规环境
- 主要进展
- 产业趋势
第四章 全球成人疫苗市场：依疫苗类型划分，2021-2033年
- 流感
- 肝炎
- 人类乳突病毒（HPV）
- 肺炎球菌
- 破伤风、白喉、百日咳
- COVID-19
- 其他的
第五章 全球成人疫苗市场：依技术划分，2021-2033年
- 灭活疫苗、次单位疫苗
- 减毒活病毒疫苗
- 结合疫苗
- 基因改造疫苗
- 药效疫苗
- 类毒素疫苗
第六章 全球成人疫苗市场：依应用领域划分，2021-2033年
- 预防
- 治疗
第七章 全球成人疫苗市场：依通路划分，2021-2033年
- 医院
- 诊所
- 零售药房
- 政府和公共卫生项目
- 其他的
第八章 全球成人疫苗市场：依地区划分，2021-2033年
- 北美洲
- 我们
- 加拿大
- 拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲
- 欧洲
- 德国
- 英国
- 西班牙
- 法国
- 义大利
- 俄罗斯
- 其他欧洲国家
- 亚太地区
- 中国
- 印度
- 日本
- 澳洲
- 韩国
- ASEAN
- 亚太其他地区
- 中东
- 海湾合作委员会国家
- 以色列
- 其他中东国家
- 非洲
- 南非
- 北非
- 中非
第九章 竞争情势
- Pfizer Inc
- GlaxoSmithKline plc
- Merck &Co Inc
- Sanofi
- Johnson and Johnson
- Moderna
- AstraZeneca plc
- CSL Limited
- Serum Institute of India
- Bharat Biotech
第十章 分析师建议
- 机会
- 分析师意见
- Coherent Opportunity Map
第十一章 参考文献与调查方法
- 参考
- 调查方法
- 关于本公司
Adult Vaccines Market is estimated to be valued at USD 32.8 Bn in 2026 and is expected to reach USD 51.6 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.69% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 32.8 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 6.69% | 2033 Value Projection: | USD 51.6 Bn |
The global adult vaccines market, being a significant segment of the preventive healthcare market, aims at offering immunization solution services to individuals aged 18 years and above. This market segment is vital in the prevention of vaccine-preventable diseases and the reduction of healthcare costs.
Adult vaccines are different in the sense that they offer immunization solution services to individuals based on the risk of acquiring diseases and immunity levels in adults. This market segment offers various immunization solution services, such as influenza, pneumococcal, hepatitis, HPV, meningococcal, and travel vaccines, among other newer vaccines such as shingles and RSV.
The market growth is driven by factors such as the rising awareness of preventive healthcare, the increasing incidence of chronic diseases which compromise immunity, and the widening recommendations for vaccinations by health authorities. The COVID-19 pandemic has also helped raise the awareness and acceptability of adult vaccination, which is further driving the market growth. In addition, the development of new vaccine technologies, including mRNA, is expected to improve the efficacy of vaccines, thereby driving the market growth.
Market Dynamics
The global adult vaccines market is influenced by a number of factors that create a favorable environment for growth. For instance, an aging population is more susceptible to infections like influenza, pneumococcal disease, and shingles. In addition, an increase in diabetes and heart conditions has made adults more susceptible to infections. Government initiatives aimed at cutting healthcare costs and preventive care are also a major influence. Vaccines are also being driven by an increase in international travel and health programs at the workplace. In addition, advances in vaccine technology are making vaccines more effective and accessible to adults.
However, some factors that inhibit growth in this market are vaccine hesitancy, high R&D costs, and regulatory hurdles. In addition, poor healthcare infrastructure in some parts of the world is a major hindrance to growth.
Despite these challenges, some of the opportunities that are available in this market are a growing healthcare infrastructure in emerging markets, a rise in disposable incomes, and an increase in preventive healthcare. For instance, combination vaccines and digital technologies are making vaccines more accessible and effective.
Key Features of the Study
- This report provides in-depth analysis of the global adult vaccines market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global adult vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Pfizer Inc, GlaxoSmithKline plc, Merck & Co Inc, Sanofi, Johnson and Johnson, Moderna, AstraZeneca plc, CSL Limited , Serum Institute of India, and Bharat Biotech
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global adult vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global adult vaccines market
Market Segmentation
- Vaccine Type Insights (Revenue, USD Bn, 2021 - 2033)
- Influenza
- Hepatitis
- Human Papillomavirus (HPV)
- Pneumococcal
- Tetanus Diphtheria and Pertussis
- COVID-19
- Others
- Technology Insights (Revenue, USD Bn, 2021 - 2033)
- Inactivated and Subunit Vaccines
- Live Attenuated Vaccines
- Conjugate Vaccines
- Recombinant Vaccines
- mRNA Vaccines
- Toxoid Vaccines
- Application Insights (Revenue, USD Bn, 2021 - 2033)
- Preventive
- Therapeutic
- Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033)
- Hospitals
- Clinics
- Retail Pharmacies
- Government and Public Health Programs
- Others
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Pfizer Inc
- GlaxoSmithKline plc
- Merck & Co Inc
- Sanofi
- Johnson and Johnson
- Moderna
- AstraZeneca plc
- CSL Limited
- Serum Institute of India
- Bharat Biotech
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Adult Vaccines Market, By Vaccine Type
- Global Adult Vaccines Market, By Technology
- Global Adult Vaccines Market, By Application
- Global Adult Vaccines Market, By Distribution Channel
- Global Adult Vaccines Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Market Opportunities
- Regulatory Scenario
- Key Developments
- Industry Trends
4. Global Adult Vaccines Market, By Vaccine Type, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Influenza
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Hepatitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Human Papillomavirus (HPV)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Pneumococcal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Tetanus Diphtheria and Pertussis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- COVID-19
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Adult Vaccines Market, By Technology, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Inactivated and Subunit Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Live Attenuated Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Conjugate Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Recombinant Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- mRNA Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Toxoid Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Adult Vaccines Market, By Application, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Preventive
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Therapeutic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
7. Global Adult Vaccines Market, By Distribution Channel, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Government and Public Health Programs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
8. Global Adult Vaccines Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
9. Competitive Landscape
- Pfizer Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GlaxoSmithKline plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck & Co Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sanofi
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson and Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Moderna
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AstraZeneca plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- CSL Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Serum Institute of India
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bharat Biotech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us
